EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C46H86NO8P |
| Net Charge | 0 |
| Average Mass | 812.167 |
| Monoisotopic Mass | 811.60911 |
| SMILES | [H][C@@](COC(=O)CCCCCCC/C=C\CCCCCC)(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCC/C=C\C/C=C\CCCCC |
| InChI | InChI=1S/C46H86NO8P/c1-6-8-10-12-14-16-18-20-21-22-23-24-25-27-29-31-33-35-37-39-46(49)55-44(43-54-56(50,51)53-41-40-47(3,4)5)42-52-45(48)38-36-34-32-30-28-26-19-17-15-13-11-9-7-2/h14,16-17,19-21,44H,6-13,15,18,22-43H2,1-5H3/b16-14-,19-17-,21-20-/t44-/m1/s1 |
| InChIKey | IHEXWEKEFCKFEL-UTIGHQPQSA-N |
| Roles Classification |
|---|
| Biological Role: | metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 1-(9Z)-hexadecenoyl-2-(13Z,16Z)-docosadienoyl-sn-glycero-3-phosphocholine (CHEBI:74479) is a phosphatidylcholine 38:3 (CHEBI:64446) |
| IUPAC Name |
|---|
| (2R)-2-[(13Z,16Z)-docosa-13,16-dienoyloxy]-3-[(9Z)-hexadec-9-enoyloxy]propyl 2-(trimethylazaniumyl)ethyl phosphate |
| Synonyms | Source |
|---|---|
| PC(16:1/22:2) | HMDB |
| PC(16:1(9Z)/22:2(13Z,16Z)) | ChEBI |
| GPCho(16:1/22:2) | HMDB |
| GPCho(16:1(9Z)/22:2(13Z,16Z)) | ChEBI |
| phosphatidylcholine(16:1(9Z)/22:2(13Z,16Z)) | ChEBI |
| 1-(9Z-hexadecenoyl)-2-(13Z,16Z-docosadienoyl)-glycero-3-phosphocholine | LIPID MAPS |
| Manual Xrefs | Databases |
|---|---|
| LMGP01011496 | LIPID MAPS |
| HMDB0008020 | HMDB |